[Characteristics of the immune status of patients with uveal melanoma during the performance of organ-preserving treatment].
The paper presents data about changes in the immune status of patients with uveal melanoma in the process of organ-preserving treatment. The presence of 2 types of reaction on the treatment are shown. They are characterized by intensification or depression of the cellular immunity, in particular of its T-cellular link. The type of reaction depends on the initial state of the immune reactivity of the body, the size of the tumor and the type of the injurious factor. The increase of immune reactivity correlates with the best clinical outcomes of the treatment. This allows to use the determination of the immune status in prognosticating the outcome of treatment.
Maletskiĭ
A P
AP
Vit
V V
VV
Vanichkin
A A
AA
D000917:Antibody Formation / Q000276:immunology; D001610:Beta Particles / Q000627:therapeutic use; D002830:Choroid Neoplasms / Q000276:immunology / Q000628:therapy; D002924:Ciliary Body; D003131:Combined Modality Therapy; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007958:Leukocyte Count; D008028:Light Coagulation; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D014604:Uveal Neoplasms / Q000276:immunology* / Q000628:therapy
Osobennosti immunnogo statusa bol'nykh uveal'nymi melanomami v protsesse provedeniia organosokhrannogo lecheniia.